Rare autoimmune and autoinflammatory neurologic disorders

Verma, NK; Naik, RR; Wong, BHS; Jayaraman, A; Fazil, MHUT; Lim, KY; Cheam, MS; Yuan, JCX; Ting, JKY; Mamidi, A; Lakshminarayanan, R; Lai, KO; Wong, JH; Fairley, LH; Salvatore Vincent, A; Qi, CLZ; Verma, R; Barron, AM

Rare autoimmune and autoinflammatory neurologic disorders

Verma, NK Naik, RR Wong, BHS Jayaraman, A Fazil, MHUT Lim, KY Cheam, MS Yuan, JCX Ting, JKY Mamidi, A Lakshminarayanan, R Lai, KO Wong, JH Fairley, LH Salvatore Vincent, A Qi, CLZ Verma, R Barron, AM

Permalink

Publisher:: Elsevier
Publication Type:: Chapter
Citation:: Translational Neuroimmunology: Neuroinflammation: Volume 7, 2023, 7, pp. 189-219
Issue Date:: 2023-01-01

Closed Access

	Filename	Description	Size
	21752127_12414421030005671.pdf		438.27 kB	Adobe PDF	View/Open

Copyright Clearance Process

Recently Added
In Progress
Closed Access

This item is closed access and not available.

Full metadata record

Field	Value	Language
dc.contributor.author	Verma, NK
dc.contributor.author	Naik, RR
dc.contributor.author	Wong, BHS
dc.contributor.author	Jayaraman, A
dc.contributor.author	Fazil, MHUT
dc.contributor.author	Lim, KY
dc.contributor.author	Cheam, MS
dc.contributor.author	Yuan, JCX
dc.contributor.author	Ting, JKY
dc.contributor.author	Mamidi, A
dc.contributor.author	Lakshminarayanan, R
dc.contributor.author	Lai, KO
dc.contributor.author	Wong, JH
dc.contributor.author	Fairley, LH
dc.contributor.author	Salvatore Vincent, A
dc.contributor.author	Qi, CLZ
dc.contributor.author	Verma, R
dc.contributor.author	Barron, AM
dc.date.accessioned	2023-12-14T04:00:33Z
dc.date.available	2023-12-14T04:00:33Z
dc.date.issued	2023-01-01
dc.identifier.citation	Translational Neuroimmunology: Neuroinflammation: Volume 7, 2023, 7, pp. 189-219
dc.identifier.isbn	9780323900713
dc.identifier.uri	http://hdl.handle.net/10453/173836
dc.description.abstract	This chapter provides a comprehensive overview of the prevalence, clinical features, pathogenesis, and pathophysiology of less common autoimmune and autoinflammatory disorders that primarily affect the nervous system—autoimmune encephalitis, central nervous system (CNS) vasculitis, Hashimoto’s encephalopathy, autoimmune epilepsy, Morvan syndrome, Issacs’ syndrome, neuromyelitis optica spectrum disorders, autoimmune optic neuritis, neurosarcoidosis, neuro-Behcet’s disease, CNS lupus, myasthenia gravis, chronic inflammatory demyelinating polyradiculoneuropathy, and Lambert-Eaton myasthenic syndrome. It summarizes currently used diagnostic approaches and available therapeutic options. It also highlights associated socioeconomic impact and emphasizes needs for further research, innovation, and investment to better manage these debilitating neurologic conditions.
dc.language	en
dc.publisher	Elsevier
dc.relation.ispartof	Translational Neuroimmunology: Neuroinflammation: Volume 7
dc.relation.isbasedon	10.1016/B978-0-323-85841-0.00019-5
dc.rights	info:eu-repo/semantics/closedAccess
dc.title	Rare autoimmune and autoinflammatory neurologic disorders
dc.type	Chapter
utslib.citation.volume	7
pubs.organisational-group	/University of Technology Sydney
pubs.organisational-group	/University of Technology Sydney/Faculty of Science
pubs.organisational-group	/University of Technology Sydney/Strength - CFI - Centre for Inflammation
utslib.copyright.status	closed_access	*
dc.date.updated	2023-12-14T04:00:31Z
pubs.publication-status	Published
pubs.volume	7

Abstract:

This chapter provides a comprehensive overview of the prevalence, clinical features, pathogenesis, and pathophysiology of less common autoimmune and autoinflammatory disorders that primarily affect the nervous system—autoimmune encephalitis, central nervous system (CNS) vasculitis, Hashimoto’s encephalopathy, autoimmune epilepsy, Morvan syndrome, Issacs’ syndrome, neuromyelitis optica spectrum disorders, autoimmune optic neuritis, neurosarcoidosis, neuro-Behcet’s disease, CNS lupus, myasthenia gravis, chronic inflammatory demyelinating polyradiculoneuropathy, and Lambert-Eaton myasthenic syndrome. It summarizes currently used diagnostic approaches and available therapeutic options. It also highlights associated socioeconomic impact and emphasizes needs for further research, innovation, and investment to better manage these debilitating neurologic conditions.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/173836